Phase II trail of nab-paclitaxel in metastatic breast cancer patients with visceral metastases
Abstract Background Visceral metastases account for 48–67% of metastatic breast cancer (MBC) patients and presage a worse overall survival. Previous study suggested potential effect of nab-paclitaxel on patients with visceral metastases subgroups. This phase II trial was conducted to explore the eff...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
BMC
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/8b66bb85b7d0499482ca3c9ffebd7fdc |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|